Status:
UNKNOWN
The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Acute Coronary Syndrome
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.
Detailed Description
Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.
Eligibility Criteria
Inclusion
- treatment with enoxaparin
Exclusion
- no
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00354796
Start Date
July 1 2006
End Date
October 1 2015
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120